4.7 Article

PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity

Natasa Karas-Kuzelicki et al.

PHARMACOGENOMICS (2014)

Article Biochemistry & Molecular Biology

PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity

Gabriele Stocco et al.

HUMAN MOLECULAR GENETICS (2012)

Review Oncology

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

Ching-Hon Pui et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Pharmacology & Pharmacy

Pharmacogenetics of tomorrow: the 1+1=3 principle

Jan Pander et al.

PHARMACOGENOMICS (2010)

Review Pharmacology & Pharmacy

Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond

Natasa Karas-Kuzelicki et al.

PHARMACOGENOMICS (2009)

Article Cell Biology

The syndapin protein family: linking membrane trafficking with the cytoskeleton

MM Kessels et al.

JOURNAL OF CELL SCIENCE (2004)